Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanomaLorey Smith(Peter MacCallum Cancer Centre), Grant A. McArthur(The University of Melbourne)Nature CommunicationsMarch 1, 202210.1038/s41467-022-28705-xCited by 29SaveCiteExport RISWatch citationsRelated PapersCDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway|Cancers|2021|35